IL110888A - Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound - Google Patents

Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound

Info

Publication number
IL110888A
IL110888A IL11088894A IL11088894A IL110888A IL 110888 A IL110888 A IL 110888A IL 11088894 A IL11088894 A IL 11088894A IL 11088894 A IL11088894 A IL 11088894A IL 110888 A IL110888 A IL 110888A
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
liver diseases
vasodilating compound
vasodilating
Prior art date
Application number
IL11088894A
Other languages
English (en)
Other versions
IL110888A0 (en
Original Assignee
Pharmacy And Therapeutic Advis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacy And Therapeutic Advis filed Critical Pharmacy And Therapeutic Advis
Publication of IL110888A0 publication Critical patent/IL110888A0/xx
Publication of IL110888A publication Critical patent/IL110888A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
IL11088894A 1993-09-08 1994-09-08 Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound IL110888A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM110493 1993-09-08

Publications (2)

Publication Number Publication Date
IL110888A0 IL110888A0 (en) 1994-11-28
IL110888A true IL110888A (en) 1999-07-14

Family

ID=3777184

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11088894A IL110888A (en) 1993-09-08 1994-09-08 Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound

Country Status (14)

Country Link
EP (1) EP0717625B1 (xx)
JP (1) JP3842815B2 (xx)
KR (1) KR100350156B1 (xx)
CN (1) CN1115151C (xx)
AT (1) ATE218869T1 (xx)
CA (1) CA2170289C (xx)
DE (1) DE69430807T2 (xx)
FI (1) FI961029A0 (xx)
HK (1) HK1003422A1 (xx)
IL (1) IL110888A (xx)
NO (1) NO960866L (xx)
NZ (1) NZ273242A (xx)
SG (1) SG49645A1 (xx)
WO (1) WO1995007080A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004008A1 (en) * 1990-09-07 1992-03-19 Universidad De Alicante Composition for treating ocular pain
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation

Also Published As

Publication number Publication date
NZ273242A (en) 2001-04-27
HK1003422A1 (en) 1998-10-30
ATE218869T1 (de) 2002-06-15
CN1130874A (zh) 1996-09-11
IL110888A0 (en) 1994-11-28
CA2170289A1 (en) 1995-03-16
FI961029A (fi) 1996-03-06
JPH09502188A (ja) 1997-03-04
EP0717625A1 (en) 1996-06-26
DE69430807T2 (de) 2002-12-19
CN1115151C (zh) 2003-07-23
CA2170289C (en) 2001-05-08
SG49645A1 (en) 1999-10-19
WO1995007080A1 (en) 1995-03-16
FI961029A0 (fi) 1996-03-06
NO960866D0 (no) 1996-03-04
NO960866L (no) 1996-03-04
DE69430807D1 (de) 2002-07-18
EP0717625A4 (en) 1997-12-29
JP3842815B2 (ja) 2006-11-08
EP0717625B1 (en) 2002-06-12
KR100350156B1 (ko) 2003-02-14

Similar Documents

Publication Publication Date Title
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
DE69815122D1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
EE9900428A (et) Köhavastased ravimkoostised
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
HU229598B1 (en) Preparations for the application of anti-inflammatory agents
HUP0202525A2 (hu) Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
Newell Pharmacokinetically guided dose escalation in phase I clinical trials: Commentary and proposed guidelines.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
AU3401093A (en) Therapeutic agent for threatened abortion
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons
AR025549A1 (es) Mofetil micofelonato en asociacion con peg-ifn-alfa
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
HU9201295D0 (en) Medical preparations for treating cryptosporidiosys
HU9802896D0 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
IT1142260B (it) L-alanina come agente farmaceutico impiegato per la cura di cerebropatie vascolari e relative formulazioni
UA7971C2 (uk) Спосіб профілактики післяпологових захворювань корів
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche
ECSP003616A (es) Micofenolato mofetil en asociacion con peg-ifn-alfa

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees